FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileEbos Group Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
EBO.AX
Ebos Group Limited Stock AnalysisComprehensive stock analysis for Ebos Group Limited (EBO.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEBO.AX
EBO.AX
Ebos Group Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
EBO.AX
  1. Home
  2. Stocks
  3. Ebos Group Limited

Ebos Group Limited

🇦🇺EBO.AX•ASX

Ebos Group Limited

🇦🇺EBO.AX•ASX
P/E ratio
16.74

Your view on EBO.AX

P/E
16.74
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Ebos Group Limited

Industry
Medical - Distribution
Sector
Healthcare
CEO
Adam Luke Hall
Headquarters
737 Bourke Street, Docklands, VIC, AU
Industry
Medical - Distribution
Sector
Healthcare
CEO
Adam Luke Hall
Headquarters
737 Bourke Street, Docklands, VIC, AU
Description

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments.

The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.

It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses.

Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables.

Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986.

EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Ebos Group Limited from FRC's valuation model, read against the market price. EBO.AX last traded at AUD 18.36, 16.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Ebos Group Limited. Starting points for Ebos Group Limited: P/E 16.7, EPS AUD 1.07, beta 0.15 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Ebos Group Limited. Ebos Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Ebos Group Limited. Trailing twelve-month EPS for Ebos Group Limited stands at AUD 1.07. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.65AUD 0.73AUD 1.43AUD 1.62
Lowest estimateAUD 0.65AUD 0.73AUD 1.43AUD 1.54
Highest estimateAUD 0.65AUD 0.73AUD 1.44AUD 1.73
Number of analysts1144
A year agoAUD 0.68AUD 0.49AUD 1.04—
Growth vs a year ago−3.6%+49.8%+37.6%—

Revenue estimates

TotalThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 8.40BAUD 7.97BAUD 17.00BAUD 17.66B
Lowest estimateAUD 8.40BAUD 7.97BAUD 16.76BAUD 17.20B
Highest estimateAUD 8.40BAUD 7.97BAUD 17.26BAUD 18.02B
Number of analysts111010
A year agoAUD 5.99BAUD 6.35BAUD 12.82B—
Growth vs a year ago+40.2%+25.5%+32.6%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Ebos Group Limited. Ebos Group Limited has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold EBO.AX12 companies · 4 funds
More Medical - Distribution companies
TickerTypeCompanySectorExchangeMkt cap
ARRJFArjo AB (publ)HealthcareOTC$840.2M
BIMIBIMI International Medical Inc.HealthcareOTC$1,156
CAHCardinal Health, Inc.HealthcareNYSE$63.1B
CORCencora, Inc.HealthcareNYSE$64.7B
EBOSYEBOS Group LimitedHealthcareOTC$1.8B
ENMIDH Enchantment Inc.HealthcareOTC$383,131
EXHIExlites Holdings International, Inc.HealthcareOTC$16.0M
GALNFGalenica AGHealthcareOTC$5.8B
HIGRHi-Great Group Holding CompanyHealthcareOTC$8.2M
HSICHenry Schein, Inc.HealthcareNASDAQ$9.2B
IUSDFAS ONE CorporationHealthcareOTC$1.7B
MAHLYMediPal Holdings CorporationHealthcareOTC$4.2B
ETFs holding Ebos Group Limited
TickerFundFund assets% of the fund
VAS.AXVanguard Australian Shares Index ETF$27.0B in assets0.02%
IHD.AXiShares S&P/ASX Dividend Opportunities ESG Screened ETF$401M in assets0.17%
ISO.AXiShares S&P/ASX Small Ordinaries ETF$120M in assets0.27%
SSO.AXState Street SPDR S&P/ASX Small Ordinaries ETF$24M in assets0.27%

Largest holders first, then the funds most concentrated in EBO.AX.

Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Ebos Group Limited. Coverage tracks Ebos Group Limited within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Ebos Group Limited.

EBO.AX AnalysisWeak
Past
1
Growth
1
Health
3
Profit
2
Value
2